1-(bis(4-fluorophenyl)methyl)-4-(2,3,4-trimethoxybenzyl)piperazine dihydrochloride,
KB 2796,
KB-2796,
lomerizine,
lomerizine dihydrochloride,
Lomerizine hydrochloride,
101477-54-7,
Lomerizine dihydrochloride,
Lomerizine HCl,
Terranas,
LOMERIZINE 2HCL,
UNII-3W473D5LIY,
KB 2796,
KB-2796,
1-[BIS(4-FLUOROPHENYL)METHYL]-4-(2,3,4-TRIMETHOXYBENZYL)PIPERAZINE DIHYDROCHLORIDE,
1-[bis(4-fluorophenyl)methyl]-4-[(2,3,4-trimethoxyphenyl)methyl]piperazine dihydrochloride,
3W473D5LIY,
MFCD01703867,
1-(bis(4-fluorophenyl)methyl)-4-(2,3,4-trimethoxybenzyl)piperazine dihydrochloride,
1-(2,3,4-Trimethoxybenzyl)-4-(bis(4-fluorophenyl)methyl)piperazine dihydrochloride,
1-(Bis(4-fluorophenyl)methyl)-4-((2,3,4-trimethoxyphenyl)methyl)piperazine dihydrochloride,
DSSTox_CID_26427,
DSSTox_RID_81605,
DSSTox_GSID_46427,
Piperazine, 1-(bis(4-fluorophenyl)methyl)-4-((2,3,4-trimethoxyphenyl)methyl)-, dihydrochloride,
CAS-101477-54-7,
NCGC00164543-01,
lomerizine-hcl,
Migsis,
1-(2,3,4-trimethoxybenzyl)-4-[bis(4-fluorophenyl)methyl]piperazine dihydrochloride,
Terranas (TN),
Lomerizine Hydrochlortde,
AC1L3U0Y,
C27H32Cl2F2N2O3,
Lomerizine hydrochloride (JAN),
SCHEMBL1153647,
CHEMBL2356978,
DTXSID1046427,
C27H30F2N2O3.2HCl,
CTK6J4130,
HY-B0768A,
LOGVKVSFYBBUAJ-UHFFFAOYSA-N,
BCP12061,
Tox21_112172,
DE-090,
s4084,
AKOS015900365,
Tox21_112172_1,
AC-2040,
NCGC00164543-02,
AN-14347,
H763,
LS-110465,
RT-013592,
CS-0012057,
FT-0627971,
L0245,
SW197640-2,
A16599,
D02633,
477L547,
A800394,
I14-0643,
J-000407,
Lomerizine dihydrochloride, >=98% (HPLC), powder,
101477-54-7, 101477-55-8(free base),
1-(bis(4-fluorophenyl)methyl)-4-(2,3,4-trimethoxybenzyl)piperazine hydrochloride,
Piperazine, 1-[bis(4-fluorophenyl)methyl]-4-[(2,3,4-trimethoxyphenyl)methyl]-, hydrochloride (1:2),
lomerizine,
C27H30F2N2O3.2ClH,
ACN-S001256,
CID122125,
CL0043,
C27-H30-F2-N2-O3.2Cl-H,
B1782,
C052424,
Lomerizine dihydrochloride, 99%, a new L- and T-type calcium channel blocker - 1G 1g,